Overview of Fortadol
| Property | Description |
|---|---|
| Active Ingredients | Acetaminophen, Tramadol Hydrochloride |
| Form | Tablet (Fixed-Dose Combination) |
| Pharmacological Class | Combination Analgesic (Pain Reliever) |
| Common Use | Management of moderate to moderately severe pain |
| Origin | Synthetic |
Defining Fortadol: A Fixed-Dose Combination Analgesic
Fortadol is a prescription-only, synthetic combination analgesic designed to manage pain through the simultaneous action of two distinct ingredients. This medication is classified pharmacologically as a potent pain reliever, establishing its identity as a therapy for symptomatic discomfort. It is presented for oral administration, typically manufactured as a tablet or film-coated tablet. The two-component structure defines it as a Fixed-Dose Combination (FDC) product, a strategy often utilized in modern pain management. This structural approach is used to provide relief by targeting pain through multiple, overlapping biological pathways. This specific FDC formulation is clinically recognized for its efficacy in treating pain that is not adequately managed by non-opioid medications alone.
Composition and General Purpose
Fortadol is chemically defined by the combination of two active ingredients: Acetaminophen (a non-opioid component) and Tramadol Hydrochloride (a central-acting synthetic opioid component). This combination is widely known under the brand name Ultracet in many regions. The unique value of this product lies in its synergistic or multi-modal action, where the two compounds work together to enhance the overall effect. The pharmacological profile of the components confirms their classification as centrally acting analgesics when combined. The general purpose of Fortadol is therefore to achieve effective relief for pain categorized as moderate to moderately severe, offering robust symptomatic control through its unique dual-component mechanism, often prescribed in scenarios such as post-operative recovery or during acute musculoskeletal injury.
Regulatory References

